ArticleClinical drug investigation2025

Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Efbemalenograstim Alfa (F-627), a Novel Long-Acting rhG-CSF, in Healthy Chinese Participants: An Open-Label, Single-Center Phase I Study.

Zhihai Cao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.